上海昊海生物科技股份有限公司

Chinese medical device and pharmaceutical company founded in 2007 in Shanghai, listed on the main board of the Hong Kong Stock Exchange in April 2015 under code 6826 and on the Shanghai STAR Market in October 2019 under code 688366. Researches, manufactures and sells medical biomaterials for fast growing treatment areas in China, covering ophthalmology, plastic surgery and aesthetics and wound care, orthopaedics, and anti-adhesion and haemostasis, with products including intraocular lenses, contact lenses, hyaluronic acid dermal fillers, sodium hyaluronate injections for joints and medical chitosan products.